Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data
Biotech company Vitroscope raised $7 million, including a $5 million seed round, to develop perfusion platforms that turn living human tissue into drug discovery data. This is a deep-tech biotech raise relevant to founders building lab hardware and biological platforms.